| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/18/2000 | CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same |
| 05/18/2000 | CA2347916A1 Inhibition of the formation of vascular hyperpermeability |
| 05/18/2000 | CA2347847A1 A method of treating tumors using fas-induced apoptosis |
| 05/18/2000 | CA2346962A1 Fk506-based regulation of biological events |
| 05/17/2000 | EP1001032A2 Recombinant retroviruses delivering vector constructs to target cells |
| 05/17/2000 | EP1001025A2 Outer membrane proteins from actinobacillus pleuropneumoniae |
| 05/17/2000 | EP1001023A2 Frizzled-4, a putative Wnt-receptor |
| 05/17/2000 | EP1001022A1 CAMEL, an alternative translation product of the tumour antigen LAGE-1 |
| 05/17/2000 | EP1000166A2 Inhibitors of cell-cycle progression and uses related thereto |
| 05/17/2000 | EP1000163A1 $i(PSEUDOMONAS) EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS |
| 05/17/2000 | EP1000161A1 Anticoagulant fusion protein anchored to cell membrane |
| 05/17/2000 | EP1000158A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 05/17/2000 | EP1000149A2 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 05/17/2000 | EP1000147A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 05/17/2000 | EP1000145A1 Heart and skeleton muscle specific nucleic acid, the production and use thereof |
| 05/17/2000 | EP1000144A2 Lactoferrin receptor genes of moraxella |
| 05/17/2000 | EP1000082A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/17/2000 | EP0804413B1 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production |
| 05/17/2000 | EP0773950A4 Linked peptide nucleic acids |
| 05/17/2000 | CN1253590A Bacterial plasmids |
| 05/17/2000 | CN1253565A Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 05/17/2000 | CN1253176A Composition and method for protecting animals from diseases related with slow action virus |
| 05/17/2000 | CN1253138A Structure and usage of antisense oligonucleotide for treating diseases correlative to hepatitis C virus |
| 05/16/2000 | US6063913 Stable heterologous propagation CFTR protein variant cDNA |
| 05/16/2000 | US6063766 Drugs and proteins from blood with amino acid sequences |
| 05/16/2000 | US6063760 Proteins with amino acid sequences |
| 05/16/2000 | US6063630 Targeted introduction of DNA into primary or secondary cells and their use for gene therapy |
| 05/16/2000 | US6063623 Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, DNA sequences encoding it and their use |
| 05/16/2000 | US6063622 Adenovirus vectors |
| 05/16/2000 | US6063610 Flea hydrolase enzyme; for development of antibodies to prevent parasitic infection of plant and animals |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | US6063593 TGFβ1 responsive bone marrow derived cells to express a recombinant protein |
| 05/16/2000 | US6063585 Tumor necrosis factor receptor associated factor regulated protein product; for the prevention of tumors cause by epstein barr virus; antitumor agents |
| 05/16/2000 | US6063582 Methods of screening for compounds that interact with human P2u2 purinergic receptor |
| 05/16/2000 | US6063569 Methods for automated synthesis of PNA-DNA chimeras and compositions thereof |
| 05/16/2000 | US6063563 Method of PCR testing of pooled blood samples |
| 05/16/2000 | CA2271826A1 Methods and compositions for increasing the infectively of retroviruses |
| 05/11/2000 | WO2000026397A1 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS) |
| 05/11/2000 | WO2000026396A1 A method of recombination and agents useful for same |
| 05/11/2000 | WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 05/11/2000 | WO2000026393A1 A myeloid precursor cell useful for gene therapy and for modulation of immune responses |
| 05/11/2000 | WO2000026385A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | WO2000026379A2 Polypeptide mediating cell permeability |
| 05/11/2000 | WO2000026376A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026367A2 Therapeutics and diagnostics for ocular abnormalities |
| 05/11/2000 | WO2000026366A1 Isolated nucleic acids encoding a secretory signal for expression and secretion of heterologous recombinant proteins |
| 05/11/2000 | WO2000026365A1 NOVEL GENE AND PROTEIN ERRη ENCODED THEREBY |
| 05/11/2000 | WO2000026254A2 Antibodies binding to the aav capsid, antibodies modifying cytotropism, method for targeted gene transfer |
| 05/11/2000 | WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 05/11/2000 | WO2000026249A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | WO2000026248A2 Tuberculosis diagnostic test |
| 05/11/2000 | WO2000026247A2 Ikaros isoforms and mutants |
| 05/11/2000 | WO2000026237A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026227A1 Ldl related protein and uses thereof |
| 05/11/2000 | WO2000025827A2 Dna molecules encoding muc-1 and use thereof in tumor vaccination |
| 05/11/2000 | WO2000025804A2 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 05/11/2000 | WO2000025798A1 Treatment of parkinson's disease with oligonucleotides |
| 05/11/2000 | WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 05/11/2000 | WO2000009691A3 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 05/11/2000 | WO2000007618A3 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/11/2000 | WO2000007565A3 Methods of ophthalmic administration |
| 05/11/2000 | WO2000006189A3 Conversion of naturally-occurring quinones to quinone derivatives by macrophage migration inhibition factor and uses thereof |
| 05/11/2000 | WO1999054460A3 Human nucleic acid sequences of normal bladder tissue |
| 05/11/2000 | DE19847364C1 Tumor-Protein Tumor protein |
| 05/11/2000 | CA2773380A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | CA2350212A1 Treatment of parkinson's disease with oligonucleotides |
| 05/11/2000 | CA2349758A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 05/11/2000 | CA2349505A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | CA2349417A1 Ikaros isoforms and mutants |
| 05/11/2000 | CA2348960A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348958A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348745A1 Dna molecules encoding muc-1 and use thereof in tumor vaccination |
| 05/11/2000 | CA2348736A1 A myeloid precursor cell useful for gene therapy and for modulation of immune responses |
| 05/11/2000 | CA2348475A1 Tuberculosis diagnostic test |
| 05/11/2000 | CA2317117A1 Ldl related protein and uses thereof |
| 05/10/2000 | EP0999280A2 Episomally replicating vector, its preparation and use |
| 05/10/2000 | EP0999279A1 Gene transfer method with the use of serum-free medium |
| 05/10/2000 | EP0999278A1 Vascular specific regulatory elements contained in the desmin 5' flanking region |
| 05/10/2000 | EP0999270A1 Method of regulating SMN gene expression |
| 05/10/2000 | EP0999268A1 New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof |
| 05/10/2000 | EP0998945A1 Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy |
| 05/10/2000 | EP0998582A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 05/10/2000 | EP0998577A1 Conjugates of transporter peptides and nucleic acid analogs, and their use |
| 05/10/2000 | EP0998576A2 Bovine adenovirus type 3 genome |
| 05/10/2000 | EP0998570A1 Recombinant lysostaphin analogs |
| 05/10/2000 | EP0998568A1 Mutant having uracil phosphoribosyl transferase activity |
| 05/10/2000 | EP0998565A1 Interleukin-3 gene therapy for cancer |
| 05/10/2000 | EP0998561A1 Trail receptor |
| 05/10/2000 | EP0998560A1 Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression |
| 05/10/2000 | EP0998501A1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy |
| 05/10/2000 | EP0998492A1 Composition and methods for the treatment of inflammatory diseases |
| 05/10/2000 | EP0998307A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 05/10/2000 | EP0998306A1 Liposomal compositions for the delivery of nucleic acid catalysts |
| 05/10/2000 | EP0998301A1 Nucleic acid based immunotherapy of chronic hepatitis b infection |
| 05/10/2000 | CN1252840A Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof |
| 05/10/2000 | CN1252689A Combined tumor suppressor gene therapy and chemotherapy in treatment of neoplasms |
| 05/10/2000 | CN1252450A Construction and application of serial universal adenovirus accompanying virus carriers |
| 05/10/2000 | CN1252441A Recombined-adenovirus accompanying virus production method and application |
| 05/10/2000 | CA2287775A1 Attenuated forms of bovine viral diarrhea virus |
| 05/09/2000 | US6060595 Inhibition of viral replication |